HTG Molecular Diagnostics Announces Certain Preliminary 2021 Unaudited Financial Results
January 06, 2022 08:00 ET
|
HTG Molecular Diagnostics, Inc.
Preliminary full year 2021 unaudited revenue of $8.9 million Cash, cash equivalents and short-term marketable securities of $21.9 million as of December 31, 2021 TUCSON, Ariz., Jan. 06, 2022 ...
HTG Completes HTP Product Next-Phase Development Milestone
December 22, 2021 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Dec. 22, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Expands Therapeutics Scientific Advisory Board With Addition of Dr. Jerald Radich
December 16, 2021 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Dec. 16, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Announces Major Sales Milestone for HTG Transcriptome Panel
December 09, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Dec. 09, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG and Icahn School of Medicine at Mount Sinai Announce Bladder Cancer Research Collaboration
November 17, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Nov. 17, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 15, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Nov. 15, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics Reports Third Quarter 2021 Results
November 10, 2021 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Nov. 10, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics to Announce Third Quarter 2021 Financial Results and Host Conference Call on Wednesday, November 10
November 02, 2021 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Nov. 02, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company advancing precision medicine through its transcriptome-wide technology, today...
HTG Expands Therapeutics Team
October 05, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Oct. 05, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
September 21, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Sept. 21, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that...